Nonviral vectors in the new millennium: delivery barriers in gene transfer.
about
Microbubble Compositions, Properties and Biomedical ApplicationsIn vitro correction of cystic fibrosis epithelial cell lines by small fragment homologous replacement (SFHR) technique.Delivery of oligonucleotides with lipid nanoparticlesGene therapy for ocular diseases meditated by ultrasound and microbubbles (Review)Insight concerning the mechanism of therapeutic ultrasound facilitating gene delivery: increasing cell membrane permeability or interfering with intracellular pathways?Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors.Advances in ultrasound mediated gene therapy using microbubble contrast agents.Low-amplitude ultrasound enhances hydrodynamic-based gene delivery to rat kidney.Simultaneous gene transfer of bone morphogenetic protein (BMP) -2 and BMP-7 by in vivo electroporation induces rapid bone formation and BMP-4 expression.Tumor-directed gene therapy in mice using a composite nonviral gene delivery system consisting of the piggyBac transposon and polyethylenimine.Nanodelivery in airway diseases: challenges and therapeutic applications.Identification and functional characterization of cytoplasmic determinants of plasmid DNA nuclear import.Polymeric Materials for Gene Delivery and DNA VaccinationMicroporation is a valuable transfection method for efficient gene delivery into human umbilical cord blood-derived mesenchymal stem cellsA pH and redox dual responsive 4-arm poly(ethylene glycol)-block-poly(disulfide histamine) copolymer for non-viral gene transfection in vitro and in vivoEvaluation of biolistic gene transfer methods in vivo using non-invasive bioluminescent imaging techniquesGene transfer into the lung by nanoparticle dextran-spermine/plasmid DNA complexesNetwork analysis of endogenous gene expression profiles after polyethyleneimine-mediated DNA deliveryAdvanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction.Cardiac gene therapyThe efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen.Gene therapy for cardiovascular disorders: is there a future?Gene repair in the new age of gene therapy.Nontoxic genetic engineering of mesenchymal stem cells using serum-compatible pullulan-spermine/DNA anioplexes.Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safetySynergetic Targeted Delivery of Sleeping-Beauty Transposon System to Mesenchymal Stem Cells Using LPD Nanoparticles Modified with a Phage-Displayed Targeting Peptide.Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression.Release of bioactive adeno-associated virus from fibrin scaffolds: effects of fibrin glue concentrations.Hepatic insulin gene therapy in insulin-dependent diabetes mellitus.Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome.Microarray analysis of gene expression profiles in cells transfected with nonviral vectors.Insight into the efficient transfection activity of a designed low aggregated magnetic polyethyleneimine/DNA complex in serum-containing medium and the application in vivo.Characterization of degradable polyelectrolyte multilayers fabricated using DNA and a fluorescently-labeled poly(β-amino ester): shedding light on the role of the cationic polymer in promoting surface-mediated gene delivery.Gene therapy of benign gynecological diseases.Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticlesEfficient Nonviral Gene Therapy Using Folate-Targeted Chitosan-DNA Nanoparticles In VitroApplications of gene therapy for familial amyloidotic polyneuropathy.Formulation Strategies, Characterization, and In Vitro Evaluation of Lecithin-Based Nanoparticles for siRNA Delivery.Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection.Incorporation of DOPE into Lipoplexes formed from a Ferrocenyl Lipid leads to Inverse Hexagonal Nanostructures that allow Redox-Based Control of Transfection in High Serum.
P2860
Q24631069-C194EA2B-F844-4FC0-B75A-67143EDFD5CFQ24792158-33243D22-068E-4ED2-BAF3-F65B083E24C7Q27024646-EEE52996-F6A2-45E3-B47B-3D3DA033E3D7Q30397703-BD340DD9-76AB-48CB-B023-BEA51CA93A3DQ30419720-6FB80742-B72A-4F36-8D78-B8F72EB48DB2Q30447306-EAB6244B-ABBD-4629-84FB-5A044C192AC9Q30458491-2C75ED5F-E33E-49A7-89B4-506C20BEB889Q30479994-FF67160B-8E70-4211-AE18-BBF1239B2A41Q33252751-27AEA1EB-D023-40DA-B446-FB5ECDC53789Q33435664-3DE6B931-6CF9-465C-A762-25ABE19F8632Q33483926-D3C1951E-1913-4B8D-ACF9-2B367255AE4EQ33488141-C8DD81FF-14DE-4D7B-909D-37F97D0831B8Q33565296-CFFA7B01-65E0-4CDB-BECB-75762A5F1965Q33576396-86CC3EAB-DF8A-418E-8692-D6BD19914245Q33755943-0073751D-1EEA-4511-9D31-2749541CE16DQ33920307-0270D334-13A7-4B48-8BEB-B74B66C0B4D1Q33960002-C1AD4B3F-9595-4487-9814-7021CA2ECBA6Q33971133-6B900117-3C7A-4F64-BDF4-DCFE1DB44C1FQ34329754-E4FF27A2-EF4D-4225-B831-77213BF2638EQ34409721-4A5DAC30-0D2B-4CEE-BEC5-B0F3A23F040FQ34482074-C0C05B8D-B527-403A-A147-83C6E88B3831Q34497315-FC99E5C8-19EE-40AE-A56B-E8FE0C490612Q34547463-64767D63-7407-4A20-9F20-BFF7FB241B66Q34645099-1429C42A-DF33-4467-82CF-621C3B820D58Q34687112-C0A253C3-1148-4523-9A85-01D38F7AEDB5Q34864807-0B873560-0BEC-4475-B8DB-46574EF51E9AQ35110751-FD999284-1724-4142-9378-E3756F653DE7Q35125051-D4594B76-0FBF-4034-8184-F84674FD297BQ35544053-020F93DF-0190-49BA-AE53-625C9B60C538Q35552189-36E8EFFA-A164-4A4D-8F17-7FBF3C1A4442Q35623449-DD6BE94F-08B0-4340-8C6F-917735652EEDQ35723051-6D376E2E-E423-45B3-BBE8-1344BD14FD28Q35753972-9180C9E5-013C-46BA-AE13-1573009123E5Q35770271-D7783F58-71AA-45AA-9849-BA00A1F646E1Q35846835-4054CDF2-9DD8-48B7-914D-88C5BD45D3F7Q35864390-FACE6203-CA51-4737-9183-22188922EE54Q35907026-FB42F8AC-EF63-4171-A8A5-50E92AB2F8DCQ35909205-E72ED82A-5849-4324-A43D-5AC69ED5FCACQ36009111-6793FF42-0D79-4560-9FD4-1171D0C14EC1Q36030078-28B382C0-A2B3-468C-8D98-E207F33BE3B6
P2860
Nonviral vectors in the new millennium: delivery barriers in gene transfer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Nonviral vectors in the new millennium: delivery barriers in gene transfer.
@ast
Nonviral vectors in the new millennium: delivery barriers in gene transfer.
@en
Nonviral vectors in the new millennium: delivery barriers in gene transfer.
@nl
type
label
Nonviral vectors in the new millennium: delivery barriers in gene transfer.
@ast
Nonviral vectors in the new millennium: delivery barriers in gene transfer.
@en
Nonviral vectors in the new millennium: delivery barriers in gene transfer.
@nl
prefLabel
Nonviral vectors in the new millennium: delivery barriers in gene transfer.
@ast
Nonviral vectors in the new millennium: delivery barriers in gene transfer.
@en
Nonviral vectors in the new millennium: delivery barriers in gene transfer.
@nl
P1433
P1476
Nonviral vectors in the new millennium: delivery barriers in gene transfer.
@en
P2093
P304
P356
10.1089/104303401750195836
P577
2001-05-01T00:00:00Z